Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study.
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
Genetic predictors of relapse rate in pediatric MS.
Experimental protocol of a randomized controlled clinical trial investigating exercise, subclinical atherosclerosis, and walking mobility in persons with multiple sclerosis.
Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Cardiovascular adaptation in people with multiple sclerosis following a twelve week exercise programme suggest deconditioning rather than autonomic dysfunction caused by the disease Results from a randomized controlled trial.
Purines in neurodegeneration and neuroregeneration.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.
[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Acute inflammatory myelopathies.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Effect of treadmill training on fatigue in multiple sclerosis: a pilot study.
Multiple sclerosis drugs: how much bang for the buck?
Relation of Demographics and Reported Symptoms and Medication Use in Persons with Multiple Sclerosis.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Pages
« first
‹ previous
…
447
448
449
450
451
452
453
454
455
…
next ›
last »